A complete application in a minute
Tailored resume and cover letter, ready to send.
Regeneron is seeking a Regional Access Lead to drive market access, pricing and reimbursement strategies across Europe within a hybrid work setup. You will align regional actions with global objectives, monitor payer trends, and engage with payers, policymakers and patient groups to shape evidence and HEOR programs.
The role requires extensive European market access experience, strong negotiation skills, and fluent English; additional European languages and neurology experience are advantageous.
Build our future together: At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Regional Access Lead to join our Market Access function, supporting our European region in a hybrid work mode. In this role, you will drive market access, pricing, and reimbursement strategies for our neurology portfolio while collaborating with global, regional, and local teams. This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.
Multiple locations are being considered for this role (Hybrid)
Lead European market access strategies aligned with global objectives and country needs. Monitor payer trends, healthcare policies, and reimbursement frameworks across Europe. Represent Europe in global access strategy discussions and shape future approaches. Adapt access tools, payer value propositions, and objection handlers for regional use. Support Health Technology Assessment dossiers, mock negotiations, and payer engagements. Build relationships with payers, policymakers, and patient advocacy groups. Align evidence generation and health economics outcomes research with payer requirements.
You bring an agile, collaborative mindset when influencing cross-functional teams.
Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law.
Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.
If you have any questions, please speak with your recruiter.
Please be advised that at Regeneron, we believe we do our best work when we are together. For that reason, many roles are required to be performed on-site. Please speak with your recruiter and hiring manager for more information about on-site expectations for your role and location.
Where necessary, we disclose salary ranges for roles in all countries in which we operate.
Salary Range (annually) €93,825.00 - €156,375.00
Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role:
For additional information about Regeneron benefits in the U.S., please visit https://careers.regeneron.com/en/working-at-regeneron/total-rewards/. For other locations, additional information will be provided during the recruitment process.
As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications.
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases.
Regeneron is also proud of award winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.